Consulter en ligne

Suggestions

Du même auteur

Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial

Archive ouverte | Tabernero, Josep | CCSD

International audience. BACKGROUND:Tumour mutational status is an important determinant of the response of metastatic colorectal cancer to targeted treatments. However, the genotype of the tissue obtained at the tim...

Randomized trial of TAS-102 for refractory metastatic colorectal cancer

Archive ouverte | Mayer, Robert J. | CCSD

International audience. BACKGROUND: Early clinical trials conducted primarily in Japan have shown that TAS-102, an oral agent that combines trifluridine and tipiracil hydrochloride, was effective in the treatment of...

Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single‐Arm, Open‐Label Phase IIIb CONSIGN Study

Archive ouverte | van Cutsem, Eric | CCSD

International audience. BACKGROUND:In the phase III CORRECT trial, regorafenib significantly improved survival in treatment-refractory metastatic colorectal cancer (mCRC). The CONSIGN study was designed to further c...

Chargement des enrichissements...